Plain-English translation of NCT03955731 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special stent called Magmaris, made from magnesium that gradually dissolves in your body, works well for treating a specific type of heart attack (STEMI). Unlike traditional stents that stay in your arteries permanently, this medication is designed to support your artery while it heals and then safely disappear, potentially reducing long-term complications.
Traditional stents remain in your heart arteries forever, which can cause problems over time. This medication offers a new approach: it scaffolds your artery during the critical healing period after a heart attack but then dissolves away naturally, potentially lowering the risk of future blockages and other complications.
You likely qualify if…
You likely don't qualify if…
You would receive the Magmaris stent implanted during your emergency heart attack treatment—this happens as part of your acute medical care, not as an additional procedure. After treatment, you would be followed closely with imaging scans and clinic visits over a 12-month period (and longer) to monitor how the stent is working and how your artery is healing as the device gradually dissolves.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Belgium